Record Information |
---|
Version | 2.0 |
---|
Creation Date | 2009-07-30 17:58:13 UTC |
---|
Update Date | 2014-12-24 20:26:02 UTC |
---|
Accession Number | T3D3428 |
---|
Identification |
---|
Common Name | Pentane |
---|
Class | Small Molecule |
---|
Description | Pentane is found in alcoholic beverages. Pentane is present in hop oil.Pentane is any or one of the organic compounds with the formula C5H12. This alkane is a component of some fuels and is employed as a specialty solvent in the laboratory. Its properties are very similar to those of butane and hexane. It exists in three structural isomers, the branched isomers are called isopentane and neopentane. Pentane is one of the primary blowing agents used in the production of polystyrene foam.
Pentane has been shown to exhibit radical scavenger function (2).
Pentane belongs to the family of Acyclic Alkanes. These are acyclic hydrocarbons consisting only of n carbon atoms and m hydrogen atoms where m=2*n + 2. |
---|
Compound Type | - Food Toxin
- Gasoline Additive/Component
- Household Toxin
- Industrial/Workplace Toxin
- Metabolite
- Natural Compound
- Organic Compound
- Plant Toxin
- Solvent
|
---|
Chemical Structure | |
---|
Synonyms | |
---|
Chemical Formula | C5H12 |
---|
Average Molecular Mass | 72.149 g/mol |
---|
Monoisotopic Mass | 72.094 g/mol |
---|
CAS Registry Number | 109-66-0 |
---|
IUPAC Name | pentane |
---|
Traditional Name | pentane |
---|
SMILES | CCCCC |
---|
InChI Identifier | InChI=1S/C5H12/c1-3-5-4-2/h3-5H2,1-2H3 |
---|
InChI Key | InChIKey=OFBQJSOFQDEBGM-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | belongs to the class of organic compounds known as alkanes. These are acyclic branched or unbranched hydrocarbons having the general formula CnH2n+2 , and therefore consisting entirely of hydrogen atoms and saturated carbon atoms. |
---|
Kingdom | Organic compounds |
---|
Super Class | Hydrocarbons |
---|
Class | Saturated hydrocarbons |
---|
Sub Class | Alkanes |
---|
Direct Parent | Alkanes |
---|
Alternative Parents | Not Available |
---|
Substituents | - Acyclic alkane
- Alkane
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Biological Properties |
---|
Status | Detected and Not Quantified |
---|
Origin | Exogenous |
---|
Cellular Locations | |
---|
Biofluid Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | Not Available |
---|
Applications | |
---|
Biological Roles | Not Available |
---|
Chemical Roles | |
---|
Physical Properties |
---|
State | Liquid |
---|
Appearance | Colorless liquid. |
---|
Experimental Properties | Property | Value |
---|
Melting Point | -129°C | Boiling Point | 36.1°C (97°F) | Solubility | 0.038 mg/mL at 25°C | LogP | 3.39 |
|
---|
Predicted Properties | |
---|
Spectra |
---|
Spectra | Spectrum Type | Description | Splash Key | Deposition Date | View |
---|
GC-MS | GC-MS Spectrum - EI-B (Non-derivatized) | splash10-0006-9000000000-0165dd3056ca8d4d0cb5 | 2017-09-12 | View Spectrum | GC-MS | GC-MS Spectrum - EI-B (Non-derivatized) | splash10-0006-9000000000-9f4d0bc46cbebba40720 | 2017-09-12 | View Spectrum | GC-MS | GC-MS Spectrum - CI-B (Non-derivatized) | splash10-05fr-9000000000-cb388ccd32b4dda52ab6 | 2017-09-12 | View Spectrum | GC-MS | GC-MS Spectrum - EI-B (Non-derivatized) | splash10-0006-9000000000-0165dd3056ca8d4d0cb5 | 2018-05-18 | View Spectrum | GC-MS | GC-MS Spectrum - EI-B (Non-derivatized) | splash10-0006-9000000000-9f4d0bc46cbebba40720 | 2018-05-18 | View Spectrum | GC-MS | GC-MS Spectrum - CI-B (Non-derivatized) | splash10-05fr-9000000000-cb388ccd32b4dda52ab6 | 2018-05-18 | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | splash10-0096-9000000000-6e6ed27bdbe4c5c6a23d | 2016-09-22 | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-00di-9000000000-b501e0856cab89e4e3ab | 2016-08-02 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-00di-9000000000-d9b92b37a042ac5c5479 | 2016-08-02 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0596-9000000000-ce740c984d3d4904ba6d | 2016-08-02 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-00di-9000000000-b2b45009e87bcf6fc9b0 | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-00di-9000000000-3029bc7f4a7e9ac563e0 | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-00di-9000000000-dad710f25814b449a52c | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-00di-9000000000-6e73363b636fec5933cb | 2021-09-22 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-01b9-9000000000-88ae36fb47fad76dda72 | 2021-09-22 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-00di-9000000000-d35ade13f5e64e28a27e | 2021-09-22 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-00di-9000000000-fbeae64eda05aa02d035 | 2021-09-22 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-00di-9000000000-257ce7ee5d4d98efdb17 | 2021-09-22 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0a4l-9000000000-2488085872f716562747 | 2021-09-22 | View Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-0006-9000000000-3d049919e62aaa7d7da8 | 2014-09-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 90 MHz, CDCl3, experimental) | Not Available | 2014-09-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 15.09 MHz, CDCl3, experimental) | Not Available | 2014-09-23 | View Spectrum |
|
---|
Toxicity Profile |
---|
Route of Exposure | Oral (4) ; inhalation (4) ; dermal (4) |
---|
Mechanism of Toxicity | Pentane is a central nervous system depressant. It affects the peripheral nervous system through demyelinization and axonal degeneration. (4) |
---|
Metabolism | Pentane is absorbed following inhalation and ingestion, and to a small extent from dermal exposure. Once in the body it distributes to the tissues and blood, with the highest concentration in the adipose tissue. Pentane is metabolized by the cytochrome P-450 system. The main metabolite is 2-pentanol, followed by 3-pentanol, and 2-pentanone. These intermediates are further metabolized to glucuronic acid conjugates or oxidized to ketone products, which are excreted in the urine and expired air. (1) |
---|
Toxicity Values | LD50: 446 mg/kg (Intravenous, Mouse) (3)
LC50: 364 g/m3 over 4 hours (Inhalation, Rat) (3) |
---|
Lethal Dose | Not Available |
---|
Carcinogenicity (IARC Classification) | Pentane is found in gasoline, which is possibly carcinogenic to humans (Group 2B). (8) |
---|
Uses/Sources | Pentanes are components of some fuels, such as gasoline, and are also used as specialty solvents in the laboratory. (7) |
---|
Minimum Risk Level | Not Available |
---|
Health Effects | Pentane is a central nervous system depressant and can cause loss of consciousness and coma at high doses. Ingestion may cause pulmonary toxicity due to pentane aspiration, including chemical pneumonitis, acute lung injury, and hemorrhage. Cardiovascular effects may include ventricular dysrhythmias and sudden death. (4, 1) |
---|
Symptoms | Pentane is a central nervous system depressant and can cause anorexia, euphoria, dizziness, headache, depression, confusion, inability to concentrate, anoxia, narcosis, and loss of consciousness and coma at high concentrations. Contact with the skin results in cause drying, erythema, hyperpigmentation, hyperemia, dermatitis, burning pain, and blisters. (3, 4, 1) |
---|
Treatment | Treatment is mainly symptomatic and supportive. Gastric lavage, emesis, and the administration of activated charcoal should be avoided, as vomiting increases the risk of aspiration. (1) |
---|
Normal Concentrations |
---|
| Not Available |
---|
Abnormal Concentrations |
---|
| Not Available |
---|
External Links |
---|
DrugBank ID | DB03119 |
---|
HMDB ID | HMDB29603 |
---|
PubChem Compound ID | 8003 |
---|
ChEMBL ID | CHEMBL16102 |
---|
ChemSpider ID | 7712 |
---|
KEGG ID | C00489 |
---|
UniProt ID | Not Available |
---|
OMIM ID | |
---|
ChEBI ID | 37830 |
---|
BioCyc ID | CPD-285 |
---|
CTD ID | Not Available |
---|
Stitch ID | n-Pentane |
---|
PDB ID | LNK |
---|
ACToR ID | 3520 |
---|
Wikipedia Link | Pentane |
---|
References |
---|
Synthesis Reference | Franz J. Broecker, Karl G. Baur, Rolf Platz, Joachim Stabenow, “Preparation of 2-methyl-pentane-2,4-diol.” U.S. Patent US4298766, issued March, 1970. |
---|
MSDS | Link |
---|
General References | - Gunther S, McMillan PJ, Wallace LJ, Muller S: Plasmodium falciparum possesses organelle-specific alpha-keto acid dehydrogenase complexes and lipoylation pathways. Biochem Soc Trans. 2005 Nov;33(Pt 5):977-80. [16246025 ]
- Sobotka PA, Brottman MD, Weitz Z, Birnbaum AJ, Skosey JL, Zarling EJ: Elevated breath pentane in heart failure reduced by free radical scavenger. Free Radic Biol Med. 1993 Jun;14(6):643-7. [8325536 ]
- Lewis RJ (1996). Sax's Dangerous Properties of Industrial Materials. 9th ed. Volumes 1-3. New York, NY: Van Nostrand Reinhold.
- Bingham, E, Cohrssen, B, and Powell, CH (2001). Patty's Toxicology Volumes 1-9. 5th ed. New York, N.Y: John Wiley & Sons.
- MICROMEDEX Thomson Health Care (2002). USPDI - Drug Information for the Health Care Professional. 22nd ed. Volume 1. Englewood, CO: MICROMEDEX Thomson Health Care. Content Reviewed and Approved by the U.S. Pharmacopeial Convention, Inc.
- Yannai, Shmuel. (2004) Dictionary of food compounds with CD-ROM: Additives, flavors, and ingredients. Boca Raton: Chapman & Hall/CRC.
- Wikipedia. Pentane. Last Updated 12 July 2009. [Link]
- International Agency for Research on Cancer (2014). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. [Link]
|
---|
Gene Regulation |
---|
Up-Regulated Genes | Not Available |
---|
Down-Regulated Genes | Not Available |
---|